How to manage an arterial hypertension resistant to drug treatment
Krzesinski, J.M.
Revue Medicale de Liege 64(3): 171-175
2009
ISSN/ISBN: 0370-629X PMID: 19418938 Document Number: 631902
The management of arterial hypertension, a well known silent killer, is still a challenge for physicians fighting for an optimal control of blood pressure values. The problem is even more complex when, after a good response, the control of blood pressure becomes again worse. Our case record underscores the different steps allowing to increase the efficacy of blood pressure management in such secondary resistant form of hypertension.
Document emailed within 1 workday
Related Documents
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071Elsener, M.; Di-Falco, F.; Vialtel, P.; Cordonnier, D.; Meftahi, H.; Denis, M.C. 1979: Control of drug resistant arterial hypertension before the stage of terminal chronic kidney failure by a weekly session of hemofiltration La Nouvelle Presse Medicale 8(9): 698-699
Shevchenko, O.S. 2003: Diagnostics and treatment of resistant arterial hypertension Likars'ka Sprava 2003(3-4): 11-14
Cuesta, V.; Cannata, J.; Herrera, J.; Maisueche, I.; Peral, V.; Redondo, C. 1981: Prazosin in the treatment of resistant arterial hypertension associated with nephropathy Revista Clinica Espanola 161(1): 37-39
Maggiore, Q.; Biagini, M.; Zoccali, C.; Misefari, M. 1975: Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 11: 222-228
Maciel, R.M.; Spritzer, N.; Spritzer, T.S.; Abichequer, M.B. 1981: Treatment of diuretic-resistant arterial hypertension - crossed comparative study of verapamil and clonidine Arquivos Brasileiros de Cardiologia 36(Suppl 1): 47-50
Sukhorukov, V.V.; Frolova, E.V.; Tereshina, O.V.; Krugomov, A.V.; Trofimov, S.I.; Goncharova, E.S. 2011: Endovascular treatment of a female patient with resistant arterial hypertension secondary to a renal artery aneurysm Angiologiia i Sosudistaia Khirurgiia 17(4): 49-52
Oliván, J.; Miranda, M.J.; Chozas, J.; Gras, B.X.; Garrido, M. 1985: Long-term efficacy of captopril in the treatment of moderate/intensive arterial hypertension resistant to 3 antihypertensive drugs Medicina Clinica 85(14): 571-574
Witkowski, A.; Januszewicz, A.; Imiela, J.; Narkiewicz, K.; Opolski, G.; Rowiński, O.; Sadowski, J.; Dudek, D.; Bryniarski, L.; Gil, R.J.; Adamczak, M.; Grajek, S.; Kądziela, J.; Prejbisz, A.; Nowicki, M. 2011: Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement Kardiologia Polska 69(11): 1208-1211
Van Zwieten, P.A. 1980: Modern concepts in the drug treatment of arterial hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 412-419
Piñeiro, F.; Gil, V.; Donis, M.; Orozco, D.; Pastor, R.; Merino, J. 1997: The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension Atencion Primaria 19(7): 372-374; 376
Bellini, G.; Faccini, L.; Battilana, G.; Carretta, R.; Rigoni, A.; Puppis, E.; Rustia, R.; Englaro, E.; Carraro, M.; Fabris, B.; Menchini, U. 1981: Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug Giornale di Clinica Medica 62(11): 789-800
Ardashev, A.V.; Zhelyakov, E.G.; Zotova, I.V.; Konev, A.V.; Khimiy, O.V.; Staferov, A.V.; Knigin, A.V.; Kolesnikov, V.N.; Maskova, N.A.; Baykulova, M.K.; Belenkov, Y.N. 2017: Clinical Aspects of Interventional Treatment of a Patient with Atrial Fibrillation Combined with Resistant Arterial Hypertension by the Method of Radiofrequency Ablation in Renal Arteries and Left Atrium Kardiologiia 57(12): 90-96
Tomov, I. 1985: Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension Vutreshni Bolesti 24(6): 39-47
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881
Yang, X.; Yang, N.; Song, H. 1996: Selective arterial catheterization in the management of drug-resistant choriocarcinoma Zhonghua Fu Chan Ke Za Zhi 31(4): 199-202
Kiesewetter, R.; Herrmann, R. 1978: Drug-induced readjustment of therapy-resistant hypertension Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 33(21): 793-795
Zeĭnalov, F.M. 1999: Clinical effect of prostenon in patients with resistant arterial hypertension and target organs complications Klinicheskaia Meditsina 77(4): 13-15
Nedogoda, S.V. 2011: Combination of perindopril and amlodipine as optimal basis for realization of desirable clinical effects in the treatment of arterial hypertension with fixed drug combination Kardiologiia 51(1): 112-120
Dworak, N.; Guelpa, G.; Robert, D. 1990: Drug-induced arterial hypertension Revue Medicale de la Suisse Romande 110(12): 1027-1031